- Previous Close
110.00 - Open
113.00 - Bid 111.60 x --
- Ask 112.00 x --
- Day's Range
111.40 - 113.60 - 52 Week Range
106.00 - 145.80 - Volume
97,425 - Avg. Volume
98,649 - Market Cap (intraday)
14.56B - Beta (5Y Monthly) 0.19
- PE Ratio (TTM)
17.75 - EPS (TTM)
6.31 - Earnings Date --
- Forward Dividend & Yield 6.00 (5.17%)
- Ex-Dividend Date Mar 18, 2025
- 1y Target Est
129.09
Nahdi Medical Company operates as a pharmaceutical retailer in the Kingdom of Saudi Arabia and the United Arab Emirates. The company offers pharmaceutical and health products, such as health and wellness, mom and baby, beauty, and everyday essential products through retail and online stores; and omni-health services, including polyclinics, telemedicine services, labs, and home healthcare. It is also involved in the wholesale and retail trade of cosmetics, pharmaceuticals, special and health food, and medical equipment. In addition, the company operates E-Pharmacist platform; and Nahdi Online, an online pharmacy. Further, it offers labor and IT consulting services. Nahdi Medical Company was incorporated in 1986 and is headquartered in Jeddah, the Kingdom of Saudi Arabia.
nahdi.sa--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 4164.SR
View MorePerformance Overview: 4164.SR
Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is Tadawul All Shares Index (^TASI.SR) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4164.SR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4164.SR
View MoreValuation Measures
Market Cap
14.30B
Enterprise Value
14.87B
Trailing P/E
17.43
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.51
Price/Book (mrq)
5.53
Enterprise Value/Revenue
1.57
Enterprise Value/EBITDA
9.23
Financial Highlights
Profitability and Income Statement
Profit Margin
8.69%
Return on Assets (ttm)
9.44%
Return on Equity (ttm)
32.51%
Revenue (ttm)
9.45B
Net Income Avi to Common (ttm)
820.72M
Diluted EPS (ttm)
6.31
Balance Sheet and Cash Flow
Total Cash (mrq)
956.81M
Total Debt/Equity (mrq)
59.15%
Levered Free Cash Flow (ttm)
797.5M